Incidence of BCL-2 gene rearrangements in Argentinean non-Hodgkin lymphoma patients: increased frequency of breakpoints outside of MBR and MCR
- PMID: 14757440
- DOI: 10.1016/j.bcmd.2003.10.001
Incidence of BCL-2 gene rearrangements in Argentinean non-Hodgkin lymphoma patients: increased frequency of breakpoints outside of MBR and MCR
Abstract
The t(14;18)(q32;q21) is the most frequent cytogenetic abnormality observed in follicular lymphoma (FL), but also occurs in diffuse large B-cell lymphoma (DLBCL). We have evaluated the frequency of this translocation in 106 Argentinean non-Hodgkin lymphoma (NHL) patients: 83 with diagnosis of FL and 23 with DLBCL. Nested (N) and long-distance PCR (LD-PCR) approaches were used. By N-PCR, a total of 42 (51%) FL cases showed BCL-2 rearrangement: 28 (34%) for major breakpoint region (MBR) and 14 (17%) for minor cluster region (mcr). By LD-PCR, additional 23 (28%) new positive cases were found: 10 (12%) for MBR and 13 (16%) for mcr. These data make a total of 65 (78%) positive cases for BCL-2 gene rearrangements. In DLBCL cases, N-PCR detected two (9%) cases with the MBR breakpoint and one (4%) with mcr. Seven (30%) new positive cases by LD-PCR were found: four (17%) for MBR and three (13%) for mcr, showing a total of 10 (43%) positive cases. Thus, both FL and DLBCL had high frequencies of breakpoints located between MBR and mcr clusters. Our N-PCR results in FL (51%; 95% CI, 40-62%) showed statistical differences with respect to the pooled data from USA (P < 0.0001) and overlapped with the frequencies from Asia and Europe. In DLBCL, no significant differences with respect to the literature were found. This data support the idea that FL may be a heterogeneous malignancy with distinct molecular pathogenesis and suggest that the geographic differences may be related with the distribution of breakpoints that are widely spread throughout the sequence stretch between MBR and mcr.
Similar articles
-
Bcl-2 gene rearrangement in Jordanian follicular and diffuse large B-cell lymphomas.Saudi Med J. 2005 Feb;26(2):251-5. Saudi Med J. 2005. PMID: 15770300
-
Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets.Genes Chromosomes Cancer. 1998 Jan;21(1):17-29. doi: 10.1002/(sici)1098-2264(199801)21:1<17::aid-gcc4>3.0.co;2-b. Genes Chromosomes Cancer. 1998. PMID: 9443038
-
Frequency of bcl-2 gene rearrangement in B-cell Non-Hodgkin's lymphoma.Asian Pac J Cancer Prev. 2009 Apr-Jun;10(2):237-40. Asian Pac J Cancer Prev. 2009. PMID: 19537891
-
t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.Nouv Rev Fr Hematol (1978). 1990;32(6):401-3. Nouv Rev Fr Hematol (1978). 1990. PMID: 2129304 Review.
-
[Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma].Pathologe. 2021 Dec;42(Suppl 2):122-128. doi: 10.1007/s00292-021-01011-x. Epub 2021 Oct 20. Pathologe. 2021. PMID: 34671837 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials